Escherichia coli vaccine - Novavax

Drug Profile

Escherichia coli vaccine - Novavax

Alternative Names: Ecovax 157

Latest Information Update: 04 Oct 1999

Price : $50

At a glance

  • Originator Novavax
  • Class Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Escherichia coli infections

Most Recent Events

  • 05 Jul 1999 New profile, split from generic Escherichia coli vaccine profile
  • 22 Dec 1998 Discontinued-I for Escherichia coli infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top